Nov. 20 (Bloomberg) -- AstraZeneca Plc will eliminate 1,400 jobs and close plants in Europe as the U.K.'s second-largest drugmaker expands cost-cutting measures amid increased competition from generic medicines.
Nov. 20 (Bloomberg) -- AstraZeneca Plc will eliminate 1,400 jobs and close plants in Europe as the U.K.'s second-largest drugmaker expands cost-cutting measures amid increased competition from generic medicines.